Edwards Lifesciences appoints David T. Feinberg to Board, effective July 10

Edwards Lifesciences Corp

David T. Feinberg, M.D. appointed to Edwards Lifesciences Board and Audit Committee, effective July 10, 2024.
Dr. Feinberg is Chairman of Oracle Health, former CEO of Cerner (acquired by Oracle in 2022).
Previously held leadership roles at Google Health, Geisinger Health, and UCLA Health.
Will receive standard non-employee director compensation per 2024 Proxy and standard indemnification agreement.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

David T. Feinberg

Director

EW · Edwards Lifesciences Corp

Effective: 2024-07-10
Filed: July 10, 2024, 7:59 PM ET

On July 10, 2024, Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), appointed David T. Feinberg, M.D. to the Company’s Board of Directors (the “Board”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David T. Feinberg was appointed as Director at Edwards Lifesciences Corp.

Action: appointed
Role: Director

Exact text from the filing

On July 10, 2024, Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), appointed David T. Feinberg, M.D. to the Company’s Board of Directors (the “Board”), effective immediately.

View on SEC.gov

Edwards Lifesciences Corp filing history →

Source: SEC EDGAR

accession 0001099800-24-000061

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.